CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 75 enrolled
Drug / intervention
mPalbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05270395
NCT05270395N/ACompleted

Piloting 'mPal,' a Multilevel Implementation Strategy to Integrate Non-hospice Palliative Care Into Advanced Stage Lung Cancer Treatment

Laurie McLouth·interventional·Posted Mar 8, 2022·Updated May 13, 2025

In Brief

A clinical study evaluating mPal for Lung Cancer. Completed, enrolled 75 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the feasibility and acceptability of mPal, a multilevel implementation strategy to improve palliative care use among advanced stage lung cancer patients receiving cancer treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer
CountriesUnited States

Timeline

N/ACompletedFinished
2023202420252026
First PostedMar 8, 2022
Enrollment StartJul 28, 2022
Primary CompletionMar 22, 2024
Study CompletionJun 1, 2024
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 4.3 years ago

Interventions

mPalbehavioral

mPal's patient content includes a multi-component web-based tool with the following: (1) a brief educational video that seeks to educate patients about palliative care; (2) and assessment of palliative care knowledge; (3) assessment of palliative care needs; and (4) an assessment of whether patients would like to meet with palliative care or discuss palliative care and their palliative care needs with their oncology provider. The provider-level component includes provider education on palliative care. The system-level component includes electronic health record modifications to facilitate palliative care discussions and referrals.